Mardia Samyoung Capillary Tubes Company Ltd (513544)
சுருக்கம்
நிகழ்வுகள்
- சமீபத்திய முடிவுகள்
- Q2 FY27, தாக்கல் செய்யப்பட்டது 26 அக். 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 3 செப். 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
Mardia Samyoung Capillary Tubes Company Ltd reported Q2 FY27 results on 26 Oct 2026: revenue ₹23.4 Cr, and net profit ₹1.0 Cr; the operating margin was 5.5%.
| Q2 FY27 (₹ கோடி) | மதிப்பு | YoY Q2 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹23.4 | — | -5.9% |
| செயல்பாட்டு லாபம் | ₹1.3 | — | -8.8% |
| நிகர லாபம் | ₹1.0 | — | -6.9% |
| EPS (₹) | 0.12 | +300.0% | -7.7% |
| செயல்பாட்டு லாப வரம்பு | 5.5% | — | — |
- லாபம் இருந்தும் FY26-இல் செயல்பாட்டுப் பணப்புழக்கம் எதிர்மறையாக இருந்தது
லாபத்தின் தரம்: வரிக்கு முந்தைய ₹1.3 கோடி லாபத்தில், ₹1.3 கோடி (100%) முக்கிய வணிகத்திலிருந்து வந்தது; மீதம் பிற வருமானம் மற்றும் ஒருமுறை வரவுகளிலிருந்து வந்தது.
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Mardia Samyoung Capillary Tubes Company Ltd reported the outcome of its Board of Directors meeting held on October 26, 2026. The board approved the unaudited standalone financial results along with the Limited Review Report for the quarter and half-year ended September 30, 2026. The meeting commenced at 08:00 PM and concluded at 08:30 PM. Specific revenue and profit figures were not detailed in this covering letter.
- Board approved unaudited standalone financial results for the period ended September 30, 2026
- Board meeting held on October 26, 2026, commencing at 08:00 PM and ending at 08:30 PM
- Limited Review Report from Statutory Auditors taken on record
Mardia Samyoung Capillary Tubes Company Ltd held a Board meeting on September 03, 2026, approving the notice for its 34th AGM scheduled on September 29, 2026. The Board recommended the appointment of M/s S K Bhavsar & Co. as Statutory Auditors and M/s Shekhawat & Associates as Secretarial Auditors, both for 5-year tenures (FY 2026-27 to FY 2030-31). Additionally, the Board approved shifting the company's registered office from Maharashtra to Gujarat, subject to shareholder and statutory approvals.
- 34th Annual General Meeting scheduled for Tuesday, September 29, 2026, at 2:00 PM IST
- Appointment of M/s S K Bhavsar & Co. as Statutory Auditors for 5 consecutive years (FY 2026-27 to FY 2030-31)
- Appointment of M/s Shekhawat & Associates as Secretarial Auditors for 5 consecutive years
- Approval of Registered Office relocation from the State of Maharashtra to the State of Gujarat
Mardia Samyoung Capillary Tubes Company Ltd has scheduled a Board of Directors meeting for September 3, 2026. The board will consider convening the forthcoming Annual General Meeting (AGM) and approving the Directors' Report for FY 2025-26. Additionally, the board will evaluate a proposal to shift the company's registered office from Maharashtra to Gujarat, which will be subject to shareholder and regulatory approvals.
- Board meeting scheduled for Thursday, September 03, 2026
- Proposal to shift registered office from Maharashtra to Gujarat under consideration
- Approval of AGM notice, date, venue, and agenda on the schedule
- Approval of Directors' Report for FY 2025-26 on the agenda
Mardia Samyoung Capillary Tubes Company Ltd has informed exchanges about the launch of its new functional website (www.mardiasygltd.com) pursuant to Regulation 46 of SEBI LODR Regulations. This follows the acquisition of the company as a going concern under a liquidation process. The company stated that it is in the process of populating the website with mandatory disclosures and information.
- New functional website launched at www.mardiasygltd.com pursuant to Regulation 46 of SEBI LODR
- Filing follows the acquisition of the company as a going concern under the liquidation process
- Intimation submitted to BSE on August 19, 2026 under scrip code 513544
Mardia Samyoung reported a net profit of Rs 1.05 Cr on revenue of Rs 24.84 Cr for the quarter ended June 30, 2026. However, the statutory auditor issued a severe 'Emphasis of Matter' stating they were unable to verify sales/purchase invoices, physical inventory, or the end-utilization of Rs 15.82 Cr raised via warrant conversion. Most critically, the company granted interest-free advances of Rs 22.84 Cr (approx. 24% of net worth) during the quarter without supporting documentation or clear business rationale. The company also appears to have shifted its primary business segment to 'Trading of Agriculture Product'.
- Revenue from operations reported at Rs 24.84 Cr for the quarter ended June 30, 2026.
- Net profit stood at Rs 1.05 Cr, a turnaround from a loss of Rs 0.23 Cr in the year-ago quarter.
- Raised Rs 15.82 Cr through the conversion of 1,17,15,000 warrants into equity shares.
- Auditor flagged Rs 22.84 Cr in interest-free advances given without documentation or business rationale.
- Auditor unable to verify physical inventory or sales/purchase invoices for the quarter.
Mardia Samyoung Capillary Tubes approved its unaudited standalone financial results for the quarter ended June 30, 2026, in a board meeting held on August 11, 2026. The company also announced a relocation of its corporate office from Gandhinagar to Ahmedabad (Thaltej) effective immediately. This follows a volatile period where revenue jumped from zero in early FY26 to Rs 61.12 Cr in Q4 FY26. Investors should remain cautious as promoter holding significantly dropped from 69.41% to 26.46% in the quarter ending March 2026.
- Board approved unaudited standalone financial results for the quarter ended June 30, 2026
- Corporate office shifted to Ahmedabad (Thaltej) from Gandhinagar effective August 11, 2026
- Board meeting concluded within 1 hour, starting at 08:00 PM and ending at 09:00 PM
- Promoter holding recently saw a sharp decline of 42.95% to reach 26.46% as of March 2026
Mardia Samyoung Capillary Tubes has scheduled a board meeting for August 11, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026. The company is coming off a high-growth period where FY26 revenue reached Rs 73.87 Cr compared to zero in FY25. However, investors should be aware of the significant promoter stake reduction from 69.41% in December 2025 to 26.46% in March 2026. The company maintains a small market cap of Rs 55 Cr with zero debt.
- Board meeting scheduled for August 11, 2026, to approve Q1 results
- Reviewing performance for the period ended June 30, 2026
- Company reported a significant revenue jump to Rs 61.12 Cr in the March 2026 quarter
- Promoter holding recently decreased to 26.46% from 69.41%
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
